Fatty liver: a link to cardiovascular disease--its natural history, pathogenesis, and treatment - PubMed (original) (raw)

Review

Fatty liver: a link to cardiovascular disease--its natural history, pathogenesis, and treatment

Howard P Monsour Jr et al. Methodist Debakey Cardiovasc J. 2012 Jul-Sep.

Abstract

Nonalcoholic fatty liver disease (NAFLD) has become the most prevalent liver disease in western society and is increasing in parallel with the worldwide epidemic of obesity. It exists in a simple form, steatosis, or a more complex and more dangerous form, steatohepatitis, and it is often but not always associated with the metabolic syndrome. NAFLD can progress to cirrhosis and hepatocellular carcinoma. It is responsible for the majority of cryptogenic cirrhosis cases. Increasingly, NAFLD and its more sinister form, steatohepatitis, have been linked to the increased incidence of cardiovascular disease (CVD) worldwide, independent of the metabolic syndrome. Death from CVD surpasses death from liver complications, but that is beginning to change as people are living longer with CVD. In this article, we will review nonalcoholic fatty liver disease and its epidemiology, prevalence, pathology, and link to CVD.

Keywords: cardiovascular disease; fatty liver disease; metabolic syndrome; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis.

PubMed Disclaimer

Figures

Figure 1

Figure 1

References

    1. Brunt EM, Janney CG, DiBisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999 Sep;94(9):2476–74. - PubMed
    1. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis. 2001;21(1):3–16. - PubMed
    1. Brunt EM. Pathology of fatty liver disease. Mod Pathol. 2007 Feb;20 Suppl 1:S40–8. - PubMed
    1. Vernon G, Baranova A, Younossi ZM. Systemic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011 Aug;34(3):274–85. - PubMed
    1. Kunde SS, Lazemby AJ, Clement RH, Abrams GA. Spectrum of NAFLD and diagnostic implications of the proposed new normal range for Serum ALT in obese women. Hepatology. 2005 Sep;42(3):650–6. - PubMed

Publication types

MeSH terms

LinkOut - more resources